EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Disease modification in chronic spontaneous urticaria

Marcus Maurer, Pavel Kolkhir, Manuel P Pereira, Frank Siebenhaar, Ellen Witte-Händel, Karl-Christian Bergmann, Hanna Bonnekoh, Thomas Buttgereit, Joachim W Fluhr, Stefan Frischbutter, Eva Maria Grekowitz, Leonie Herzog und 15 weitere

Allergy · 2024-09 · 79 (9) · 2396-2413

DOI: 10.1111/all.16243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 24.07.2024. Verfasst von Marcus Maurer und 26 weiteren Autor:innen. Beteiligte Einrichtung: Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Univers…. Hauptthemen laut MEDLINE: Chronic Urticaria. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic spontaneous urticaria (CSU) is a debilitating, inflammatory skin condition characterized by infiltrating immune cells. Available treatments are limited to improving the signs and symptoms. There is an unmet need to develop therapies that target disease‐driving pathways upstream of mast cell activation to inhibit or delay the progression of CSU and associated comorbidities. Here, we aim to define disease modification due to a treatment intervention and criteria that disease‐modifying treatments (DMTs) must meet in CSU. We have defined disease modification in CSU as a favorable treatment‐induced change in the underlying pathophysiology and, therefore, the disease course, which is clinically beneficial and enduring. A DMT must fulfil the following criteria: (1) prevents or delays the progression of CSU, (2) induces long‐term, therapy‐free clinical remission, which is the sustained absence of CSU signs and symptoms without the need for treatment, and (3) affects the underlying mechanism of CSU, as demonstrated by an effect on disease‐driving signals and/or a biomarker. DMTs in CSU should slow disease progression, achieve long‐lasting disease remission, target disease‐driving mechanisms, reduce mast cell‐activating IgE autoantibodies, target cytokine profile polarization, and normalize the gut microbiome and barrier. Treating CSU at the immune system level could provide valuable alternatives to pharmacotherapy in CSU management. Specific DMTs in CSU are yet to be developed, but some show potential benefits, such as inhibitors of Bruton's Tyrosine Kinase, IL‐4 and IL‐13. Future therapies could prevent CSU signs and symptoms, achieve long‐term clinical benefits after discontinuing treatment, and prevent associated concomitant disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaHumansDisease ManagementMast CellsTreatment OutcomeDisease Progression

Stichwörter der Autor:innen

chronic spontaneous urticariadisease modificationdisease‐driving signalsdisease‐modifying treatmentstherapy‐free clinical remission

Autor:innen und Institutionen

  • Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.

Zitieren

APA

Maurer, M., Kolkhir, P., Pereira, M. P., Siebenhaar, F., Witte-Händel, E., Bergmann, K. C., Bonnekoh, H., Buttgereit, T., Fluhr, J. W., Frischbutter, S., Grekowitz, E. M., Herzog, L., Kiefer, L. A., Krause, K., Magerl, M., Muñoz, M., Neisinger, S., Nojarov, N., Prins, S., …, & Metz, M. (2024). Disease modification in chronic spontaneous urticaria. Allergy, 79(9), 2396-2413. https://doi.org/10.1111/all.16243

Vancouver

Maurer M, Kolkhir P, Pereira MP, Siebenhaar F, Witte-Händel E, Bergmann KC, et al. Disease modification in chronic spontaneous urticaria. Allergy. 2024;79(9):2396-2413. doi:10.1111/all.16243

BibTeX
@article{Maurer2024,
  author = {Maurer, Marcus and Kolkhir, Pavel and Pereira, Manuel P and Siebenhaar, Frank and Witte-Händel, Ellen and Bergmann, Karl-Christian and Bonnekoh, Hanna and Buttgereit, Thomas and Fluhr, Joachim W and Frischbutter, Stefan and Grekowitz, Eva Maria and Herzog, Leonie and Kiefer, Lea Alice and Krause, Karoline and Magerl, Markus and Muñoz, Melba and Neisinger, Sophia and Nojarov, Nicole and Prins, Samantha and Pyatilova, Polina and Ramanauskaité, Aisté and Scheffel, Jörg and Terhorst-Molawi, Dorothea and Treudler, Regina and Weller, Karsten and Zuberbier, Torsten and Metz, Martin},
  title = {Disease modification in chronic spontaneous urticaria},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {9},
  pages = {2396--2413},
  doi = {10.1111/all.16243}
}
Kostenlos starten →